Asia-Pacific FMD Vaccine Market

Published Jun 01, 2026

Length 350 Pages

SKU # DAABD21414211

Description

The Asia-Pacific FMD vaccine market is expected to reach USD 2.07 billion by 2033 from USD 1.17 billion in 2025, growing with a CAGR of 7.5% in the forecast period of 2026 to 2033.

Market Segmentation:
By Vaccine Type (Conventional Vaccines, Next-Generation / Advanced Vaccines, Others), By Type (Multivalent Vaccines, Monovalent Vaccines), By Vaccination Route (Intramuscular, Subcutaneous, Others), By Animal Type (Bovine, Porcine, Ovine, Caprine, others), By Formulation Type (Liquid Vaccines, Lyophilized (Freeze-Dried) Vaccines, Others), By Application (Routine Prophylactic Vaccination, Emergency Vaccination (Outbreak Control), Others), By End User (Commercial Livestock Farms, Veterinary Hospitals, Veterinary Care Centers, Vaccination Centers, Others), By Distribution Channel (Direct Sales (Government Procurement & Tender Supply), Retail Sales, Others), By Country (China, India, South Korea, Indonesia, Thailand, Malaysia, Hong Kong, Taiwan, Rest of Asia-Pacific). Industry Trends and Forecast to 2033.

Overview of Asia-Pacific FMD Vaccine Market Dynamics:

Drivers
• Growth in Asia-Pacific livestock population
• Rising prevalence of FMD outbreaks
• Growing government vaccination programs
• Increasing awareness of animal health and biosecurity
Restraints
• Limited cold chain infrastructure
• Vaccine hesitancy and field challenges
Opportunitites
• Integration of digital veterinary surveillance systems
• Rising adoption of multivalent and high-potency vaccines
• Emerging markets with high livestock populations
Challenges
• Viral mutation and serotype variability
• Enforcement of vaccination regulations
Market Players:

The key players operating in the Asia-Pacific FMD Vaccine market are:
• Zoetis (US)
• Boehringer Ingelheim (Germany)
• Wuhan Institute of Biological Products Co., Ltd. (China)
• Ceva Santé Animale (France)
• Botswana Vaccine Institute (Botswana)
• Biogénesis Bagó (Argentina)
• Indian Immunologicals Ltd. (India)
• Brilliant Bio Pharma Ltd. (India)
• CAHIC (China)
• Vetal Animal Health (India)
• Vecol S.A. (Netherlands)
• Biovet Pvt. Ltd. (India)
• Limor de Colombia (Colombia)
• MEVAC (Egypt)
• Kenya Veterinary Vaccines Production Institute (Kenya)
• National Veterinary Institute (Ethiopia)
• Jinyu Bio-Technology (China)
• Shanghai Shen Lian Biomedical Corporation (China)
• Shchelkovo Biocombinat (Russia)
• Dollvet (Turkey)
• Enimmune Corp. (US)

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Asia-pacific Fmd Vaccine Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Primary Interviews With Key Opinion Leaders; 2.8 Dbmr Market Position Grid; 2.9 Market Application Coverage Grid; 2.10 Vendor Share Analysis; 2.11 Econdary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestal Analysis; 4.2 Porters Five Forces Analysis; 4.3 Epidemiology Of Foot-and-mouth Disease (Fmd); 4.3.1 Fmd Incidence Rate By Species And Region; 4.3.1.1 Incidence By Species And Morbidity Burden; 4.3.1.2 Prevalence Patterns And Regional Serotype Distribution; 4.3.2 Vaccination Coverage Rate; 4.4 Mortality And Morbidity Impact; 4.4.1 Vaccine Compliance And Program Adherence; 4.4.2 Disease Containment Success Rates; 4.5 Industry Insights; 4.5.1 Micro And Macro Economic Factors; 4.5.2 Penetration And Growth Prospect Mapping; 4.5.3 Key Pricing Strategies; 4.5.4 Interviews With Specialists; 4.5.5 Analysis And Recommendation; 4.6 Company Evaluation Quadrant; 4.7 Distribution Of Products And Projects By Phase Asia-pacific Fmd Vaccine Market; 4.8 Distribution Of Projects By Scientific Approach And Phase Asia-pacific Fmd Vaccine Market; 4.9 Distribution Of Projects By Species And Phase Asia-pacific Fmd Vaccine Market; 4.10 Asia-pacific Clinical Trial Market For Asia-pacific Fmd Vaccine Market; 4.11 Healthcare Tariffs Impact Analysis; 4.11.1 Overview; 4.11.2 Tariff Structures; 4.11.2.1 Asia-pacific Vs. Regional Tariff Structures; 4.11.2.2 United States: Usda/Aphis Tariff Policies, Animal Health Program Models; 4.11.2.2.1 European Union: Cross-border Trade Regulations, Subsidy Policies; 4.11.2.2.2 Asia-pacific: Import And Export Controls On Veterinary Vaccines; 4.11.2.2.3 Emerging Markets: Challenges In Tariff Implementation; 4.11.3 Pharmaceutical (Veterinary Biologics) Tariffs And Trade Barriers; 4.11.3.1 Import Duties On Vaccines And Biologicals; 4.11.3.2 Impact On Affordability And Access In Rural Areas; 4.11.3.3 Key Trade Agreements Affecting Animal Health Product Tariffs; 4.11.4 Impact Of Healthcare Tariffs On Providers And Farmers; 4.11.4.1 Cost Burden On Commercial Farms And Veterinarians; 4.11.4.2 Effect On Vaccine Affordability And Herd Coverage; 4.11.4.3 Tariffs And Impact On Animal Trade/Movement; 4.11.5 Trade Agreements And Animal Health Tariffs; 4.11.5.1 Wto Regulations On Veterinary Products; 4.11.5.2 Impact Of Trade Wars On Vaccine Supply Chain; 4.11.5.3 Role Of Free Trade Agreements (Ftas) In Tariff Reduction; 4.11.6 Impact Of Tariffs On Veterinary Vaccine Costs & Accessibility; 4.11.7 Importance Of Tariffs In The Animal Health Sector; 4.12 Marketed Vaccine Analysis; 4.12.1 Vaccine Brand & Generic Name / Antigenic Strain; 4.12.2 Indication; 4.12.3 Pharmacological Class Of The Vaccine; 4.12.4 Primary Indication; 4.12.5 Market Status; 4.12.6 Vaccine Type (Conventional, Next-gen, Etc.); 4.12.7 Dosage Form; 4.12.8 Dosage Availability; 4.12.9 Packaging Type; 4.12.10 Route Of Administration; 4.12.11 Dosing Frequency; 4.12.12 Vaccine Insight; 4.12.13 Overview Of Development Activities (Approvals, Safety, Efficacy, Market Exclusivity); 4.12.13.1 Forecast Market Outlook; 4.12.14 Cross Competition (By Strain/Valency); 4.12.15 Therapeutic Portfolio; 4.12.16 Current Development Scenario; 4.13 Patent Analysis; 4.13.1 Patent Quality And Strength; 4.13.2 Country Patent Landscape; 4.13.3 Ip Strategy And Management; 4.13.4 Licensing And Collaboration; 4.14 Top Entities Based On R&D Glance For Asia-pacific Fmd Vaccine Market; 4.15 Market Access; 4.15.1 10-year Market Forecast; 4.15.2 Clinical Trial Recent Updates; 4.15.3 Annual New Vaccine Approvals (Oie/Regional Authorities); 4.15.4 Leading Manufacturers And Strategic Deals; 4.15.5 Major Vaccine Uptake; 4.15.6 Current Vaccination Practices; 4.15.7 Impact Of Upcoming Technologies And Therapy; 4.16 R & D Analysis; 4.16.1 Comparative Analysis; 4.16.2 Vaccine Development Landscape; 4.16.3 In-depth Insights On Regulatory Milestones; 4.16.4 Therapeutic Assessment; 4.16.5 Asset-based Collaborations And Partnerships
5 War-driven Disruption In Veterinary Vaccine Supply Chains, Geographic Footprints, Structural Changes, And Adaptive Strategies: 5.1 Supply Chain Resilience; 5.1.1 Diversification Of Antigen And Adjuvant Ingredient Suppliers; 5.1.2 Establishment Of Regional Veterinary Vaccine Manufacturing Hubs; 5.1.3 Strategic Stockpiling Of Emergency Vaccine Banks; 5.1.4 Development Of Alternative Cold Chain Logistics Routes; 5.1.5 Strategic Partnerships With Contract Manufacturers (Cdmos); 5.1.6 Expansion Of Vaccine Fill-finish And Packaging Capacities; 5.2 Energy & Manufacturing Operational Cost Risk; 5.2.1 Rising Energy Costs In Animal Health Production Facilities; 5.2.2 Increased Costs For Biologics Raw Materials And Components; 5.2.3 Long-term Energy Procurement Strategies For Veterinary Plants; 5.2.4 Adoption Of Energy-efficient Biopharma Manufacturing Technologies; 5.2.5 Deployment Of Advanced Automation And Continuous Manufacturing; 5.2.6 Integration Of Renewable Energy In Veterinary Vaccine Plants; 5.3 Geographic Footprint Reassessment; 5.3.1 Expansion Of Vaccine Production In Politically Stable Regions; 5.3.2 Diversification Of Asia-pacific Veterinary Vaccine Bases; 5.3.3 Relocation Of Antigen Production Facilities; 5.3.4 Expansion Of Manufacturing In Emerging Animal Health Markets; 5.3.5 Establishment Of Regional Veterinary Vaccine Distribution Hubs; 5.4 Scenario Planning & Risk Management; 5.4.1 Development Of Supply Chain Contingency Plans For Outbreaks; 5.4.2 Multi-source Procurement Strategies For Key Vaccine Ingredients; 5.4.3 Government And Animal Health Authority Collaborations; 5.4.4 Crisis-response Vaccine Deployment Networks; 5.4.5 Deployment Of Supply Chain Analytics In Vaccine Distribution; 5.5 Cash & Financial Protection; 5.5.1 Strengthening Capital Reserves For Manufacturing Expansion; 5.5.2 Diversification Of Product Portfolios And Revenue Streams; 5.5.3 Investments In Domestic Vaccine Manufacturing Infrastructure; 5.5.4 Government Incentives For Animal Health Production; 5.5.5 Long-term Procurement Agreements With Governments And Organizations; 5.6 Data Protection; 5.6.1 Data Protection Frameworks For Animal Health R&D And Manufacturing; 5.6.2 Protection Of Veterinary Clinical Trial And Field Data; 5.6.3 Secure Cloud Infrastructure For Vaccine Data Management; 5.6.4 Ai-driven Threat Detection In Research And Supply Networks; 5.6.5 Compliance With Asia-pacific Animal Health Data Regulations And Gxp Standards
6 Regulatory Framework For Fmd Vaccines: 6.1 Regulatory Approval Process For Fmd Vaccines; 6.1.1 International Norms And Standards For Fmd Vaccines; 6.1.2 Biosafety And Containment Regulations; 6.2 Geographies’ Ease Of Regulatory Approval; 6.3 Regulatory Approval Pathways For Veterinary Vaccines; 6.4 Licensing And Registration Requirements; 6.5 Post-marketing Surveillance For Veterinary Products; 6.6 Good Manufacturing Practices (Gmp) Guidelines For Animal Health
7 Market Overview: 7.1 Drivers; 7.1.1 Growth In Asia-pacific Livestock Population; 7.1.2 Rising Prevalence Of Fmd Outbreaks; 7.1.3 Growing Government Vaccination Programs; 7.1.4 Increasing Awareness Of Animal Health And Biosecurity; 7.2 Restraints; 7.2.1 Limited Cold Chain Infrastructure; 7.2.2 Vaccine Hesitancy And Field Challenges; 7.3 Opportunities; 7.3.1 Integration Of Digital Veterinary Surveillance Systems; 7.3.2 Rising Adoption Of Multivalent And High-potency Vaccines; 7.3.3 Emerging Markets With High Livestock Populations; 7.4 Challenges; 7.4.1 Viral Mutation And Serotype Variability; 7.4.2 Enforcement Of Vaccination Regulations
8 Asia-pacific Fmd Vaccine Market, By Product Type: 8.1 Overview; 8.2 Conventional Vaccines; 8.3 Next-generation / Advanced Vaccines; 8.4 Others; 8.5 Asia-pacific Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); 8.5.1 Conventional Vaccines; 8.5.2 Next-generation / Advanced Vaccines; 8.5.3 Others
9 Asia-pacific Fmd Vaccine Market, By Type: 9.1 Overview; 9.2 Inactivated (Killed) Vaccines; 9.3 Live Attenuated Vaccines; 9.4 Asia-pacific Conventional Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.4.1 Asia-pacific; 9.4.2 Europe; 9.4.3 North America; 9.4.4 South America; 9.4.5 Middle East And Africa; 9.5 Asia-pacific Next-generation / Advanced Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); 9.5.1 Recombinant Vector-based Vaccines; 9.5.2 Virus-like Particle (Vlp) Vaccines; 9.5.3 Subunit Vaccines; 9.5.4 Others; 9.6 Asia-pacific Conventional Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.6.1 Asia-pacific; 9.6.2 Europe; 9.6.3 North America; 9.6.4 South America; 9.6.5 Middle East And Africa; 9.7 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.7.1 Asia-pacific; 9.7.2 Europe; 9.7.3 North America; 9.7.4 South America; 9.7.5 Middle East And Africa; 9.8 Asia-pacific Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); 9.8.1 Multivalent Vaccines; 9.8.2 Monovalent Vaccines; 9.9 Asia-pacific Multivalent Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.9.1 Asia-pacific; 9.9.2 Europe; 9.9.3 North America; 9.9.4 South America; 9.9.5 Middle East And Africa; 9.10 Asia-pacific Monovalent Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.10.1 Asia-pacific; 9.10.2 Europe; 9.10.3 North America; 9.10.4 South America; 9.10.5 Middle East And Africa
10 Asia-pacific Fmd Vaccine Market, By Vaccination Route: 10.1 Overview; 10.2 Intramuscular; 10.3 Subcutaneous; 10.4 Others; 10.5 Asia-pacific Intramuscular In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 10.5.1 Asia-pacific; 10.5.2 Europe; 10.5.3 North America; 10.5.4 South America; 10.5.5 Middle East And Africa; 10.6 Asia-pacific Subcutaneous In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 10.6.1 Asia-pacific; 10.6.2 Europe; 10.6.3 North America; 10.6.4 South America; 10.6.5 Middle East And Africa; 10.7 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 10.7.1 Asia-pacific; 10.7.2 Europe; 10.7.3 North America; 10.7.4 South America; 10.7.5 Middle East And Africa
11 Asia-pacific Fmd Vaccine Market, By Animal Type: 11.1 Overview; 11.2 Bovine; 11.3 Porcine; 11.4 Ovine; 11.5 Caprine; 11.6 Others; 11.7 Asia-pacific Bovine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.7.1 Asia-pacific; 11.7.2 Europe; 11.7.3 North America; 11.7.4 South America; 11.7.5 Middle East And Africa; 11.8 Asia-pacific Porcine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.8.1 Asia-pacific; 11.8.2 Europe; 11.8.3 North America; 11.8.4 South America; 11.8.5 Middle East And Africa; 11.9 Asia-pacific Ovine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.9.1 Asia-pacific; 11.9.2 Europe; 11.9.3 North America; 11.9.4 South America; 11.9.5 Middle East And Africa; 11.10 Asia-pacific Caprine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.10.1 Asia-pacific; 11.10.2 Europe; 11.10.3 North America; 11.10.4 South America; 11.10.5 Middle East And Africa; 11.11 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.11.1 Asia-pacific; 11.11.2 Europe; 11.11.3 North America; 11.11.4 South America; 11.11.5 Middle East And Africa
12 Asia-pacific Fmd Vaccine Market, By Formulation Type: 12.1 Overview; 12.2 Liquid Vaccines; 12.3 Lyophilized (Freeze-dried) Vaccines; 12.4 Others; 12.5 Asia-pacific Liquid Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 12.5.1 Asia-pacific; 12.5.2 Europe; 12.5.3 North America; 12.5.4 South America; 12.5.5 Middle East And Africa; 12.6 Asia-pacific Lyophilized (Freeze-dried) Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 12.6.1 Asia-pacific; 12.6.2 Europe; 12.6.3 North America; 12.6.4 South America; 12.6.5 Middle East And Africa; 12.7 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 12.7.1 Asia-pacific; 12.7.2 Europe; 12.7.3 North America; 12.7.4 South America; 12.7.5 Middle East And Africa
13 Asia-pacific Fmd Vaccine Market, By Application: 13.1 Overview; 13.2 Routine Prophylactic Vaccination; 13.3 Emergency Vaccination (Outbreak Control); 13.4 Others; 13.5 Asia-pacific Routine Prophylactic Vaccination In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 13.5.1 Asia-pacific; 13.5.2 Europe; 13.5.3 North America; 13.5.4 South America; 13.5.5 Middle East And Africa; 13.6 Asia-pacific Emergency Vaccination (Outbreak Control) In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 13.6.1 Asia-pacific; 13.6.2 Europe; 13.6.3 North America; 13.6.4 South America; 13.6.5 Middle East And Africa; 13.7 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 13.7.1 Asia-pacific; 13.7.2 Europe; 13.7.3 North America; 13.7.4 South America; 13.7.5 Middle East And Africa
14 Asia-pacific Fmd Vaccine Market, By End User: 14.1 Overview; 14.2 Commercial Livestock Farms; 14.3 Veterinary Hospitals; 14.4 Veterinary Care Centers; 14.5 Vaccination Centres; 14.6 Others; 14.7 Asia-pacific Commercial Livestock Farms In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.7.1 Asia-pacific; 14.7.2 Europe; 14.7.3 North America; 14.7.4 South America; 14.7.5 Middle East And Africa; 14.8 Asia-pacific Veterinary Hospitals In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.8.1 Asia-pacific; 14.8.2 Europe; 14.8.3 North America; 14.8.4 South America; 14.8.5 Middle East And Africa; 14.9 Asia-pacific Veterinary Care Centers In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.9.1 Asia-pacific; 14.9.2 Europe; 14.9.3 North America; 14.9.4 South America; 14.9.5 Middle East And Africa; 14.10 Asia-pacific Vaccination Centres In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.10.1 Asia-pacific; 14.10.2 Europe; 14.10.3 North America; 14.10.4 South America; 14.10.5 Middle East And Africa; 14.11 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.11.1 Asia-pacific; 14.11.2 Europe; 14.11.3 North America; 14.11.4 South America; 14.11.5 Middle East And Africa
15 Asia-pacific Fmd Vaccine Market, By Distribution Channel: 15.1 Overview; 15.2 Direct Sales (Government Procurement & Tender Supply); 15.3 Retail Sales; 15.4 Others; 15.5 Asia-pacific Direct Sales (Government Procurement & Tender Supply) In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 15.5.1 Asia-pacific; 15.5.2 Europe; 15.5.3 North America; 15.5.4 South America; 15.5.5 Middle East And Africa; 15.6 Asia-pacific Retail Sales In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); 15.6.1 Hospital Pharmacy; 15.6.2 Retail Pharmacy; 15.6.3 Online Pharmacy; 15.7 Asia-pacific Retail Sales In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 15.7.1 Asia-pacific; 15.7.2 Europe; 15.7.3 North America; 15.7.4 South America; 15.7.5 Middle East And Africa; 15.8 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 15.8.1 Asia-pacific; 15.8.2 Europe; 15.8.3 North America; 15.8.4 South America; 15.8.5 Middle East And Africa
16 Asia-pacific Fmd Vaccine Market, By Region: 16.1 Asia Pacific; 16.1.1 India; 16.1.2 China; 16.1.3 Indonesia; 16.1.4 Thailand; 16.1.5 Malaysia; 16.1.6 South Korea; 16.1.7 Taiwan; 16.1.8 Hong Kong; 16.1.9 Rest Of Apac
17 Asia-pacific Fmd Vaccine Market: Company Landscape: 17.1 Company Share Analysis: Global
18 Swot Analysis
19 Company Profiles: 19.1 Boehringer Ingelheim International Gmbh.; 19.1.1 Company Snapshot; 19.1.2 Company Share Analysis; 19.1.3 Product Portfolio; 19.1.4 Recent Development; 19.2 Ceva Santé Animale; 19.2.1 Company Snapshot; 19.2.2 Company Share Analysis; 19.2.3 Product Portfolio; 19.2.4 Recent Development; 19.3 China Animal Husbandry Industry Co., Ltd.; 19.3.1 Company Snapshot; 19.3.2 Revenue Analysis; 19.3.3 Company Share Analysis; 19.3.4 Product Portfolio; 19.3.5 Recent Development; 19.4 Indian Immunologicals Ltd.; 19.4.1 Company Snapshot; 19.4.2 Company Share Analysis; 19.4.3 Product Portfolio; 19.4.4 Recent Development; 19.5 Biogénesis Bagó; 19.5.1 Company Snapshot; 19.5.2 Company Share Analysis; 19.5.3 Product Portfolio; 19.5.4 Recent Development; 19.6 Biovet Private Ltd; 19.6.1 Company Snapshot; 19.6.2 Product Portfolio; 19.6.3 Recent Development; 19.7 Brilliant Bio Pharma; 19.7.1 Company Snapshot; 19.7.2 Product Portfolio; 19.7.3 Recent Development; 19.8 Dollvet; 19.8.1 Company Snapshot; 19.8.2 Product Portfolio; 19.8.3 Recent Development; 19.9 Enimmune Corp.; 19.9.1 Company Snapshot; 19.9.2 Revenue Analysis; 19.9.3 Product Portfolio; 19.9.4 Recent Development; 19.10 Jinyu Biotechnology Co., Ltd.; 19.10.1 Company Snapshot; 19.10.2 Revenue Analysis; 19.10.3 Product Portfolio; 19.10.4 Recent Development; 19.11 Kenya Veterinary Vaccines Production Institute; 19.11.1 Company Snapshot; 19.11.2 Product Portfolio; 19.11.3 Recent Development; 19.12 Limor De Colombia Sas; 19.12.1 Company Snapshot; 19.12.2 Product Portfolio; 19.12.3 Recent Development; 19.13 Mevac For Vaccines; 19.13.1 Company Snapshot; 19.13.2 Product Portfolio; 19.13.3 Recent Development; 19.14 National Veterinary Institute; 19.14.1 Company Snapshot; 19.14.2 Product Portfolio; 19.14.3 Recent Development; 19.15 Shchelkovo Biocombinat; 19.15.1 Company Snapshot; 19.15.2 Product Portfolio; 19.15.3 Recent Development; 19.16 Shanghai Shen Lian Biomedical Corporation; 19.16.1 Company Snapshot; 19.16.2 Revenue Analysis; 19.16.3 Product Portfolio; 19.16.4 Recent Development; 19.17 Vetal S.A.; 19.17.1 Company Snapshot; 19.17.2 Product Portfolio; 19.17.3 Recent Development; 19.18 Vecol; 19.18.1 Company Snapshot; 19.18.2 Product Portfolio; 19.18.3 Recent Development; 19.19 Wuhan Institute Of Biological Products Co., Ltd.; 19.19.1 Company Snapshot; 19.19.2 Product Portfolio; 19.19.3 Recent Development; 19.20 Zoetis Services Llc; 19.20.1 Company Snapshot; 19.20.2 Revenue Analysis; 19.20.3 Product Portfolio; 19.20.4 Recent Development
20 Questionnaire
21 Related Reports: list Of Tables; Table 1 Asia-pacific Fmd Vaccine Pricing Structure; Table 2 Fmd Serotype Prevalence By Region; Table 3 Economic Impact Of Fmd Outbreaks; Table 4 Manufacturer Positioning Map; Table 5 Fmd Incidence, Morbidity, And Epidemiological Rates; Table 6 Fmd Serotype Prevalence By Region; Table 7 Distribution Of Products And Projects By Phase Asia-pacific Fmd Vaccine Market; Table 8 Distribution Of Projects By Scientific Approach And Phase Asia-pacific Fmd Vaccine Market; Table 9 Distribution Of Projects By Species And Phase Asia-pacific Fmd Vaccine Market; Table 10 Asia-pacific Clinical Trial Market For Asia-pacific Fmd Vaccine Market; Table 11 Dosage Form Characteristics Of Fmd Vaccines; Table 12 Dosage Availability Of Marketed Fmd Vaccines; Table 13 Therapeutic Portfolio Diversification In Fmd Vaccines; Table 14 Asia-pacific Fmd Vaccine Market, By Vaccine Type, 2025; Table 15 Asia-pacific Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); Table 16 Asia-pacific Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Per Unit); Table 17 Asia-pacific Conventional Vaccines In Fmd Vaccine Market, By Type, 2025; Table 18 Asia-pacific Conventional Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 19 Asia-pacific Next-generation / Advanced Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 20 Asia-pacific Conventional Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 21 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 22 Asia-pacific Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 23 Asia-pacific Multivalent Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 24 Asia-pacific Monovalent Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 25 Asia-pacific Fmd Vaccine Market, By Vaccination Route, 2018-2033 (Usd Thousand); Table 26 Asia-pacific Intramuscular In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 27 Asia-pacific Subcutaneous In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 28 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 29 Asia-pacific Fmd Vaccine Market, By Animal Type, 2018-2033 (Usd Thousand); Table 30 Asia-pacific Bovine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 31 Asia-pacific Porcine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 32 Asia-pacific Ovine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 33 Asia-pacific Caprine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 34 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 35 Asia-pacific Fmd Vaccine Market, By Formulation Type, 2018-2033 (Usd Thousand); Table 36 Asia-pacific Liquid Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 37 Asia-pacific Lyophilized (Freeze-dried) Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 38 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 39 Asia-pacific Fmd Vaccine Market, By Application, 2025; Table 40 Asia-pacific Routine Prophylactic Vaccination In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 41 Asia-pacific Emergency Vaccination (Outbreak Control) In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 42 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 43 Asia-pacific Fmd Vaccine Market, By End User, 2025; Table 44 Asia-pacific Commercial Livestock Farms In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 45 Asia-pacific Veterinary Hospitals In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 46 Asia-pacific Veterinary Care Centers In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 47 Asia-pacific Vaccination Centres In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 48 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 49 Asia-pacific Fmd Vaccine Market, By Distribution Channel, 2025; Table 50 Asia-pacific Direct Sales (Government Procurement & Tender Supply) In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 51 Asia-pacific Retail Sales In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 52 Asia-pacific Retail Sales In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 53 Asia-pacific Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 54 Asia-pacific Fmd Vaccine Market, By Country, 2018-2033 (Usd Thousand); Table 55 Asia-pacific Fmd Vaccine Market, By Country, 2018-2033 (Usd Thousand); Table 56 Asia-pacific; Table 57 Asia-pacific Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Thousand); Table 58 Asia-pacific Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); Table 59 Asia-pacific Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Per Unit); Table 60 Asia-pacific Conventional Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 61 Asia-pacific Next-generation / Advanced Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 62 Asia-pacific Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 63 Asia-pacific Fmd Vaccine Market, By Vaccination Route, 2018-2033 (Usd Thousand); Table 64 Asia-pacific Fmd Vaccine Market, By Animal Type, 2018-2033 (Usd Thousand); Table 65 Asia-pacific Fmd Vaccine Market, By Formulation Type, 2018-2033 (Usd Thousand); Table 66 Asia-pacific Fmd Vaccine Market, By Application, 2018-2033 (Usd Thousand); Table 67 Asia-pacific Fmd Vaccine Market, By End User, 2018-2033 (Usd Thousand); Table 68 Asia-pacific Fmd Vaccine Market, Bydistribution Channel, 2018-2033 (Usd Thousand); Table 69 Asia-pacific Retail Sales In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 70 India; Table 71 India Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Thousand); Table 72 India Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); Table 73 India Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Per Unit); Table 74 India Conventional Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 75 India Next-generation / Advanced Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 76 India Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 77 India Fmd Vaccine Market, By Vaccination Route, 2018-2033 (Usd Thousand); Table 78 India Fmd Vaccine Market, By Animal Type, 2018-2033 (Usd Thousand); Table 79 India Fmd Vaccine Market, By Formulation Type, 2018-2033 (Usd Thousand); Table 80 India Fmd Vaccine Market, By Application, 2018-2033 (Usd Thousand); Table 81 India Fmd Vaccine Market, By End User, 2018-2033 (Usd Thousand); Table 82 India Fmd Vaccine Market, By Distribution Channel, 2018-2033 (Usd Thousand); Table 83 India Retail Sales In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 84 China; Table 85 China Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Thousand); Table 86 China Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); Table 87 China Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Per Unit); Table 88 China Conventional Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 89 China Next-generation / Advanced Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 90 China Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 91 China Fmd Vaccine Market, By Vaccination Route, 2018-2033 (Usd Thousand); Table 92 China Fmd Vaccine Market, By Animal Type, 2018-2033 (Usd Thousand); Table 93 China Fmd Vaccine Market, By Formulation Type, 2018-2033 (Usd Thousand); Table 94 China Fmd Vaccine Market, By Application, 2018-2033 (Usd Thousand); Table 95 China Fmd Vaccine Market, By End User, 2018-2033 (Usd Thousand); Table 96 China Fmd Vaccine Market, By Distribution Channel, 2018-2033 (Usd Thousand); Table 97 China Retail Sales In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 98 Indonesia; Table 99 Indonesia Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Thousand); Table 100 Indonesia Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); Table 101 Indonesia Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Per Unit); Table 102 Indonesia Conventional Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 103 Indonesia Next-generation / Advanced Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 104 Indonesia Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 105 Indonesia Fmd Vaccine Market, By Vaccination Route, 2018-2033 (Usd Thousand); Table 106 Indonesia Fmd Vaccine Market, By Animal Type, 2018-2033 (Usd Thousand); Table 107 Indonesia Fmd Vaccine Market, By Formulation Type, 2018-2033 (Usd Thousand); Table 108 Indonesia Fmd Vaccine Market, By Application, 2018-2033 (Usd Thousand); Table 109 Indonesia Fmd Vaccine Market, By End User, 2018-2033 (Usd Thousand); Table 110 Indonesia Fmd Vaccine Market, By Distribution Channel, 2018-2033 (Usd Thousand); Table 111 Indonesia Retail Sales In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 112 Thailand; Table 113 Thailand Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Thousand); Table 114 Thailand Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); Table 115 Thailand Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Per Unit); Table 116 Thailand Conventional Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 117 Thailand Next-generation / Advanced Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 118 Thailand Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 119 Thailand Fmd Vaccine Market, By Vaccination Route, 2018-2033 (Usd Thousand); Table 120 Thailand Fmd Vaccine Market, By Animal Type, 2018-2033 (Usd Thousand)

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now